Dantrolene
Sponsors
Department of Medicine and Clinical Science Yamaguchi University, Medical University of Vienna, University of Massachusetts, Worcester, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
Cerebral VasospasmCerebral Vasospasm After Subarachnoid HemorrhageHealthy VolunteersHyperthermiaLumbar Spine InjuryMultiple SclerosisStatins Induced MyopathySubarachnoid Hemorrhage
Phase 1
Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage
CompletedNCT00964548
Start: 2007-07-31End: 2009-10-31Updated: 2012-05-25
Safety Study of Dantrolene in Subarachnoid Hemorrhage
CompletedNCT01024972
Start: 2009-10-31End: 2013-10-31Updated: 2015-03-05
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
RecruitingNCT03109288
Start: 2017-08-11End: 2029-01-01Target: 250Updated: 2026-04-01
Phase 2
Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH)
TerminatedNCT00796900
Start: 2008-05-31End: 2011-03-31Target: 34Updated: 2011-05-12
Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate
CompletedNCT01950520
Start: 2014-02-07End: 2024-06-11Updated: 2024-10-16
The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery
CompletedNCT03762109
Start: 2019-07-29End: 2024-06-01Updated: 2024-07-11
Dantrolene in Statin-induced Myopathy
Not yet recruitingNCT06966843
Start: 2027-10-31End: 2030-03-31Target: 23Updated: 2025-05-13